SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-000293
Filing Date
2021-01-20
Accepted
2021-01-20 08:47:02
Documents
5
Period of Report
2021-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20210119x8k.htm 8-K 52068
2 EX-2.1 tmb-20210119xex2d1.htm EX-2.1 683863
3 EX-10.1 tmb-20210119xex10d1.htm EX-10.1 97436
4 EX-10.2 tmb-20210119xex10d2.htm EX-10.2 64539
5 EX-10.3 tmb-20210119xex10d3.htm EX-10.3 21011
  Complete submission text file 0001558370-21-000293.txt   920313
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33818 | Film No.: 21537480
SIC: 3845 Electromedical & Electrotherapeutic Apparatus